James Stanker
Chief Financial Officer
Replay available
Processa Pharmaceuticals, Inc. (PCSA) Q2 2022 Earnings Call
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) Q2 2022 earnings conference call, held 2022-08-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. David Young
Chief Executive Officer
Naz Rahman
Analyst, Maxim Group
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Processa Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:03.751 Good afternoon, ladies and gentlemen, and welcome to the Process of Pharmaceuticals Second 00:00:03.751 -- 00:00:09.154 Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only 00:00:09.154 -- 00:00:14.037 mode, and we will open the floor for your questions and comments after the presentation. 00:00:14.037 -- 00:00:18.219 It is now my pleasure to turn the floor over to your host, James Stanker, Chief Financial 00:00:18.219 -- 00:00:20.700 Officer of Process of Pharmaceuticals. 00:00:20.700 -- 00:00:23.241 Sir, the floor is yours. 00:00:23.241 -- 00:00:28.248 Thank you, and welcome to Process of Second Quarter 2022 Earnings 00:00:28.248 -- 00:00:32.249 results, and clinical pipeline update conference call. 00:00:32.249 -- 00:00:36.690 Joining me on the call today are our Chief Executive Officer, Dr. 00:00:36.690 -- 00:00:41.331 David Young, and our Chief Operating Officer, Mike Floyd. 00:00:41.331 -- 00:00:46.042 Shortly before this call, we filed our June 30th, 2022 00:00:46.113 -- 00:00:51.394 Form 10-Q. I want to remind everyone that a PowerPoint presentation will accompany 00:00:51.394 -- 00:00:56.473 Dr. Young's prepared remarks. To view the PowerPoint slides, please go 00:00:56.473 -- 00:01:01.654 to the investor relations section on our website or our earnings press release 00:01:01.654 -- 00:01:05.754 and click on the webcast link to follow along. 00:01:05.775 -- 00:01:09.135 I will start our call by reading the safe harbor statement. 00:01:09.135 -- 00:01:14.036 This statement is made pursuant to the safe harbor for forward-looking statements described 00:01:14.036 -- 00:01:18.937 in the Private Securities Litigation Reform Act of 1995. 00:01:18.937 -- 00:01:24.343 All statements made on ...